Health Care (CNBC)
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
Starboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly unethical."
13 hours 17 minutes ago
Checkout newsMicrosoft announces new AI tools to help ease workload for doctors and nurses
Microsoft announced a series of new health-care data and AI tools for clinicians on Thursday.
17 hours 50 minutes ago
Checkout newsFormer Pfizer CEO, finance chief step back from Starboard's activist campaign
The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was slated to meet with the CEO, sources said.
1 day 6 hours ago
Checkout newsCVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" against pharmacy benefit managers.
1 day 12 hours ago
Checkout newsOzempic underworld: Inside the black market of obesity drugs
A CNBC investigation into illegal weight loss drugs reveals a marketplace where criminals brazenly counterfeit the drugs or ship the real product from overseas.
1 day 20 hours ago
Checkout newsHealthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Pfizer's troubles may finally be coming to a head. Meanwhile, Hims & Hers is joining S&P SmallCap 600.
2 days 12 hours ago
Checkout newsWomen's health startup Maven Clinic closes funding at $1.7 billion valuation
Maven Clinic closed a $125 million funding round at a $1.7 billion valuation, the company announced Tuesday.
2 days 20 hours ago
Checkout newsApple could launch a ring to rival Samsung by 2026, research firm predicts
Apple could launch a connected ring to rival Samsung by 2026, according to CCS Insight, adding to the U.S. tech giant's focus on health.
3 days 4 hours ago
Checkout newsCVS is under pressure and considering a breakup. Here's why that could be risky
A breakup would be a stunning reversal for CVS, which has spent tens of billions of dollars on acquisitions to turn itself into a one-stop health destination.
6 days 17 hours ago
Checkout newsRecursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Recursion said it was able to use its AI-enabled drug discovery platform to identify a novel target and move all the way to gaining IND approval in less than 18 months.
1 week ago
Checkout newsOura announces new smart ring with updated design and new sensors for $349
Oura announced the Oura Ring 4, which is available for preorder starting at $349.
1 week 1 day ago
Checkout newsEli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer's disease, ALS and other brain diseases, CEO David Ricks said.
1 week 1 day ago
Checkout newsHealthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care cybersecurity following major attacks.
1 week 2 days ago
Checkout newsCVS is working with advisors on strategic review, sources say
CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter.
1 week 2 days ago
Checkout newsMajor CVS shareholder plans activist push, will meet with management, sources say
Glenview Capital is expected to meet with CVS management on Monday to discuss its plans for value creation at the struggling business.
1 week 3 days ago
Checkout newsGE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare's quiet outperformance is becoming harder to tune out.
1 week 3 days ago
Checkout newsHarris leads with Latino voters, but the economy narrows the margin for Dems: Survey
10 things to watch in the stock market Friday including a bullish call on Best Buy
Wall Street is on track for weekly gains, led by the tech-heavy Nasdaq Composite.
1 week 6 days ago
Checkout newsFDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
2 weeks ago
Checkout newsNovo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.
2 weeks 1 day ago
Checkout newsIn 51 U.S. states are published
336
Companies
199
Counties
250
Cities
The 5 newest Companies
1977 N Park Pl SE, Atlanta, GA 30339
19520 Heritage Oak Blvd, Port Charlotte, FL 33948
525 E Victoria Trails Blvd, DeLand, FL 32724
1834 Mayflower Ave # D, Monrovia, CA 91016
5755 SW Erickson Ave, Beaverton, OR 97005
Other Companies
2806 Trailing Vine Rd, Spring, TX 77373
27 E De La Guerra St, Santa Barbara, CA 93101
911 W B St, Russellville, AR 72801
102 Eagle Pkwy, Centerville, GA 31028
7342 Orangethorpe Ave, Buena Park, CA 90621